Myocardial ischemia – reperfusion injury

Aim. To summarize and broaden the idea about mechanisms of acute coronary insufficiency development and pathophysiological features of myocardial reperfusion injury. Today, in the event of acute coronary syndrome, according to the latest recommendations for myocardial revascularization, percutane...

Full description

Bibliographic Details
Main Authors: S. V. Salo, V. O. Shumakov, S. S. Shpak, V. V. Tokhtarov
Format: Article
Language:English
Published: Zaporozhye State Medical University 2023-10-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/279461/282136
_version_ 1797659648254279680
author S. V. Salo
V. O. Shumakov
S. S. Shpak
V. V. Tokhtarov
author_facet S. V. Salo
V. O. Shumakov
S. S. Shpak
V. V. Tokhtarov
author_sort S. V. Salo
collection DOAJ
description Aim. To summarize and broaden the idea about mechanisms of acute coronary insufficiency development and pathophysiological features of myocardial reperfusion injury. Today, in the event of acute coronary syndrome, according to the latest recommendations for myocardial revascularization, percutaneous coronary intervention should be performed to determine the anatomy of coronary artery lesions and further percutaneous therapy. But in some patients, after blood flow restoration, reperfusion injury occurs, which is primarily related to the duration of ischemia, infarct size, and the myocardial resistance to ischemia. Treatment of myocardial infarction, like any treatment method, has evolved. In the 60s of the previous century, it included morphine, oxygen, warfarin and bed rest for 4–6 weeks. Then, during the 70s, it consisted of morphine, oxygen, lidocaine, warfarin, bed rest for 2–3 weeks and possibly coronary angiography for the further bypass surgery. The late 1970s saw the rapid progress in thrombolysis, first intravenous and then intracoronary. And starting in the early 1980s, since G. Hartzler performed the first balloon angioplasty for acute coronary artery occlusion, the stage of mechanical myocardial reperfusion has come. At the same time, knowledge about the pathophysiology of acute coronary ischemia was deepened. The World Health Organization developed ECG criteria for acute myocardial infarction using population-based studies in the 1950s–1970s, and additional four normative European regulations since then were issued defining concepts, key points of diagnosis and possible complications of myocardial infarction. Conclusions. The development of myocardial ischemic-reperfusion injury is a staged process that has a complex pathogenesis, its own clinical manifestations, and an association with more negative long-term outcomes of myocardial infarction treatment. Its main components are myocardial swelling involving cardiomyocytes, endotheliocytes, and the interstitial space; downregulation of cytoskeleton and disruption of sarcolemma integrity; increased vascular wall permeability; spasm of arterioles; intravascular accumulation of platelets and leukocytes, and the resultant the most severe form of myocardial damage is intramyocardial hemorrhage. Clinically, this is manifested by the no-reflow phenomenon following percutaneous coronary intervention.
first_indexed 2024-03-11T18:18:12Z
format Article
id doaj.art-64ffa6a748e846f9a3ed67299601f5c2
institution Directory Open Access Journal
issn 2306-4145
2310-1210
language English
last_indexed 2024-03-11T18:18:12Z
publishDate 2023-10-01
publisher Zaporozhye State Medical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj.art-64ffa6a748e846f9a3ed67299601f5c22023-10-16T05:04:50ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102023-10-0125510.14739/2310-1210.2023.5.279461Myocardial ischemia – reperfusion injuryS. V. Salo0https://orcid.org/0000-0001-5456-1418V. O. Shumakov1https://orcid.org/0000-0001-5130-8759S. S. Shpak2https://orcid.org/0000-0003-1522-9265V. V. Tokhtarov3https://orcid.org/0000-0002-4621-6355National M. Amosov Institute of Cardio-Vascular Surgery affiliated to National Academy of Medical Sciences of Ukraine, KyivSI “National Scientific Center the M. D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine”, KyivNational M. Amosov Institute of Cardio-Vascular Surgery affiliated to National Academy of Medical Sciences of Ukraine, KyivNational M. Amosov Institute of Cardio-Vascular Surgery affiliated to National Academy of Medical Sciences of Ukraine, KyivAim. To summarize and broaden the idea about mechanisms of acute coronary insufficiency development and pathophysiological features of myocardial reperfusion injury. Today, in the event of acute coronary syndrome, according to the latest recommendations for myocardial revascularization, percutaneous coronary intervention should be performed to determine the anatomy of coronary artery lesions and further percutaneous therapy. But in some patients, after blood flow restoration, reperfusion injury occurs, which is primarily related to the duration of ischemia, infarct size, and the myocardial resistance to ischemia. Treatment of myocardial infarction, like any treatment method, has evolved. In the 60s of the previous century, it included morphine, oxygen, warfarin and bed rest for 4–6 weeks. Then, during the 70s, it consisted of morphine, oxygen, lidocaine, warfarin, bed rest for 2–3 weeks and possibly coronary angiography for the further bypass surgery. The late 1970s saw the rapid progress in thrombolysis, first intravenous and then intracoronary. And starting in the early 1980s, since G. Hartzler performed the first balloon angioplasty for acute coronary artery occlusion, the stage of mechanical myocardial reperfusion has come. At the same time, knowledge about the pathophysiology of acute coronary ischemia was deepened. The World Health Organization developed ECG criteria for acute myocardial infarction using population-based studies in the 1950s–1970s, and additional four normative European regulations since then were issued defining concepts, key points of diagnosis and possible complications of myocardial infarction. Conclusions. The development of myocardial ischemic-reperfusion injury is a staged process that has a complex pathogenesis, its own clinical manifestations, and an association with more negative long-term outcomes of myocardial infarction treatment. Its main components are myocardial swelling involving cardiomyocytes, endotheliocytes, and the interstitial space; downregulation of cytoskeleton and disruption of sarcolemma integrity; increased vascular wall permeability; spasm of arterioles; intravascular accumulation of platelets and leukocytes, and the resultant the most severe form of myocardial damage is intramyocardial hemorrhage. Clinically, this is manifested by the no-reflow phenomenon following percutaneous coronary intervention.http://zmj.zsmu.edu.ua/article/view/279461/282136myocardial infarctionacute coronary syndromestentingreperfusionno-reflow phenomenonreperfusion injury
spellingShingle S. V. Salo
V. O. Shumakov
S. S. Shpak
V. V. Tokhtarov
Myocardial ischemia – reperfusion injury
Zaporožskij Medicinskij Žurnal
myocardial infarction
acute coronary syndrome
stenting
reperfusion
no-reflow phenomenon
reperfusion injury
title Myocardial ischemia – reperfusion injury
title_full Myocardial ischemia – reperfusion injury
title_fullStr Myocardial ischemia – reperfusion injury
title_full_unstemmed Myocardial ischemia – reperfusion injury
title_short Myocardial ischemia – reperfusion injury
title_sort myocardial ischemia reperfusion injury
topic myocardial infarction
acute coronary syndrome
stenting
reperfusion
no-reflow phenomenon
reperfusion injury
url http://zmj.zsmu.edu.ua/article/view/279461/282136
work_keys_str_mv AT svsalo myocardialischemiareperfusioninjury
AT voshumakov myocardialischemiareperfusioninjury
AT ssshpak myocardialischemiareperfusioninjury
AT vvtokhtarov myocardialischemiareperfusioninjury